Loading…
National Commission on the Future of the Army Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
76pct
1d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2013 · fourth_quarter · Health Issues
Prescription drug user fee act and other issues related to generic drugs; H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 2295 Patient Safety and Generic Labeling Improvement Act; H.R. 3204 The Drug Quality and Security Act; S. 1720 Patent Transparency and Improvements Act of 2013; H.R. 3309 Innovation Act.
Client expense: Not reported · Firm income: $50,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Health Issues
Prescription drug user fee act and other issues related to generic drugs; H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 2295 Patient Safety and Generic Labeling Improvement Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Health Issues
Prescription drug user fee act and other issues related to generic drugs; H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 2295 Patient Safety and Generic Labeling Improvement Act, H.R. 3204 The Drug Quality and Security Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
Prescription drug user fee act and other issues related to generic drugs; H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 2295 Patient Safety and Generic Labeling Improvement Act.
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MD |
| Bernard Sanders | Independent | VT |
| Brian Schatz | Democratic | HI |
| Charles E. Schumer | Democratic | NY |
| Christopher A. Coons | Democratic | DE |
| Chuck Grassley | Republican | IA |
| Debbie Stabenow | Democratic | MI |
| Edward J. Markey | Democratic | MA |
| Elizabeth Warren | Democratic | MA |
| Heidi Heitkamp | Democratic | ND |
| James E. Risch | Republican | ID |
| Jeff Merkley | Democratic | OR |
| Jerry Moran | Republican | KS |
| Joe Donnelly | Democratic | IN |
| Joe Manchin, III | Independent | WV |
| John Barrasso | Republican | WY |
| John Boozman | Republican | AR |
| John D. Rockefeller, IV | Democratic | WV |
| John E. Walsh | Democratic | MT |
| John Hoeven | Republican | ND |
| John Thune | Republican | SD |
| Jon Tester | Democratic | MT |
| Kirsten E. Gillibrand | Democratic | NY |
| Lamar Alexander | Republican | TN |
| Lindsey Graham | Republican | SC |
| Marco Rubio | Republican | FL |
| Mark L. Pryor | Democratic | AR |
| Martin Heinrich | Democratic | NM |
| Mazie K. Hirono | Democratic | HI |
| Michael B. Enzi | Republican | WY |
| Mike Crapo | Republican | ID |
| Mike Johanns | Republican | NE |
| Mike Lee | Republican | UT |
| Orrin G. Hatch | Republican | UT |
| Pat Roberts | Republican | KS |
| Patrick J. Toomey | Republican | PA |
| Richard Burr | Republican | NC |
| Richard J. Durbin | Democratic | IL |
| Robert Menendez | Democratic | NJ |
| Robert P. Casey, Jr. | Democratic | PA |
| Roger F. Wicker | Republican | MS |
| Ron Wyden | Democratic | OR |
| Thad Cochran | Republican | MS |
| Tim Johnson | Democratic | SD |
| Tom Harkin | Democratic | IA |